C50.122
Malignant neoplasm of central portion of left male breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the breast, commonly known as breast cancer, can occur in males, although it is relatively rare compared to females. The specific diagnosis of ICD-10 code C50.122 refers to cancer located in the central part of the left male breast. This type of breast cancer involves abnormal, uncontrolled growth of malignant cells in the central tissue of the male breast, which can affect surrounding tissues as it progresses. Recognizing this condition early is crucial for effective management and treatment options.
Causes & Symptoms
Clinical Causes: Genetic factors, including family history of breast cancer Mutations in specific gene genes such as BRCA1 and BRCA2 Hormonal imbalances that increase estrogen levels Radiation exposure to the chest area Previous health conditions or treatments that influence breast tissue Age, as risk increases with advancing years Lifestyle factors such as alcohol consumption and obesity
Key Symptoms: A lump or thickening in the central part of the breast Changes in the appearance of the nipple or skin of the breast Nipple discharge, especially if bloody or clear Persistent pain in the breast or nipple area Swelling or redness in the breast Indentation or puckering of the skin over the affected area Unexplained changes in the size or shape of the breast
Diagnostic & Treatment
Diagnosis Path: Diagnosing malignant neoplasm of the central portion of the left male breast involves multiple steps:
Treatment Protocols: The management of this type of breast cancer typically involves a multidisciplinary approach:
Clinical Advice & FAQs
Billing Guidance
Is C50.122 a billable ICD-10 code?
Yes, C50.122 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.122?
Clinical documentation must specify the nature of Malignant neoplasm of central portion of left male breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference